Conquering Diseases

Study Of An Investigational Drug For Moderate To Severe Crohn's Disease

Description

We are looking for men and women ages 18-80 who have moderate to severe Crohn’s disease for a study of an investigational drug. The goal is to see if people can stay symptom-free and if the study medicine is safe for long-term use.

Overview

Participants in this study will be randomly assigned to get either the investigational drug or a placebo. There will be study visits every 2-4 weeks for up to 40 weeks.

What we're hoping for

We are studying if the investigational drug if the study medicine helps people with moderate to severe Crohn's Disease stay healthy, keeps their symptoms away, and is safe over time

Additional Information

ClinicalTrials.gov Identifier: NCT07184944

 Principal Investigator

Abbas  Rupawala, MD

UMass Memorial Health

 Study Contact

Anne  Foley

Anne.foley@umassmemorial.org

 Location

UMMH Memorial Campus

119 Belmont St. 

Worcester,MA 01605

508-334-1000